Globus Medical, Inc. GMED recently made a commercial launch of the ExcelsiusHub navigation system. ExcelsiusHub offers advantageous features designed to enhance spine navigation's safety and ...

Globus Medical is acquiring Nevro Corp, a spinal cord stimulator company, according to a Feb. 6 news release. Globus Medical's transaction will include all shares of Nevro, which are valued at about ...

Globus Medical’s world is about to get a little bigger, as the orthopedic devicemaker moves to acquire Nevro and its ...

Analysts said Nevro’s valuation was “inexpensive,” but the spinal cord stimulation business can benefit from Globus’ scale ...

Globus Medical (NYSE:GMED) announced today that it agreed to acquire chronic pain treatment developer Nevro (NYSE:NVRO).

Analyst Ryan Zimmerman from BTIG maintained a Buy rating on Globus Medical (GMED – Research ... is downplayed in favor of focusing on the Spine segment, there is potential for joint ...

Through the past few quarters, Globus Medical has registered above-market growth in the U.S. spine business ... including the ExcelsiusHub navigation system, opening doors to the largest market ...

Nevro has about 1,100 employees, while Globus has more than 5,000 workers. Founded in 2006, Nevro has developed the patented HFX spinal cord stimulation platform for treating chronic pain of the ...

Globus Medical expects the Nevro acquisition to be accretive to its earnings in the second year of operation. Globus Medical expects to report full financial results for 2024 and provide its updated ...